Most biopharma AI programs have the models. Few have the data foundation.
In 2025, 88% of organizations reported using AI in at least one function — yet fewer than 40% achieved measurable financial impact. The bottleneck isn't the model. It's the data underneath it.
Explore how a context-first data strategy embeds provenance, semantics, and lifecycle governance from the start to help AI scale credibly in regulated environments.
